Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology"
DOI: 10.1002/hep.32405
Abstract: Treatment of primary biliary cholangitis (PBC) with ursodeoxycholic acid (UDCA) is not always sufficient to prevent progression to hepatic decompensation and/or need for liver transplant. Adjuvant therapy with obeticholic acid may provide additional biochemical improvements… read more here.
Keywords: cell; mechanisms molecules; primary biliary; biliary cholangitis ... See more keywords